Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ortuvo logo — Pioneering the future with innovative 3D printing tools for...

Ortuvo

Pioneering the future with innovative 3D printing tools for tissue engineering and bespoke bio-inks today.

Founded 2020 Grant Total: $256.00K Biotechnology, Health Care +1

General Information

Company Name Ortuvo
Founded Year 2020
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Ortuvo. To contact Ortuvo, visit ortuvo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Ortuvo

Ortuvo, pioneering the future with innovative 3D printing tools for tissue engineering and bespoke bio-inks today, has captured the attention of the National Science Foundation, which awarded the startup a significant $256.00K grant investment on 20 April 2021. The company, founded in 2020 and based in Baltimore, Maryland, focuses on developing 3D printing research tools for tissue engineering and custom bio-inks for the healthcare and biotech industries. Ortuvo's vision and recent financial backing position them as an intriguing player in the biotechnology and healthcare sectors.

Taxonomy: 3D printing, tissue engineering, bioprinting, biotech industry, research tools, bio-inks, innovation, Maryland, startup, biomedical technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $256.00K 1
National Science Foundation
National Science Foundation
20 Apr 2021

Ortuvo Alternatives & Competitors

Ortuvo vs
KaloCyte, Inc.
KaloCyte, Inc. United States

Developing ErythroMer, bio-inspired artificial RBC substitute for use when stored blood is not avail...

Grant
20 employees
Biotechnology, Health Care
Ortuvo vs
AdBioInk Biosystem Technology
AdBioInk Biosystem Technology Turkey

All for health

2 employees
Biotechnology, Digital Health
Ortuvo vs
Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K.

Cyfuse contribute to significant advances in medical treatments and drug discovery through its revol...

Venture round
2 employees
Biotechnology, Health Care

FAQ About Ortuvo

Pioneering the future with innovative 3D printing tools for tissue engineering and bespoke bio-inks today.
Ortuvo was founded in 2020.
Ortuvo operates in Biotechnology, Health Care and Medical Devices. Its work centres on 3D printing, tissue engineering, bioprinting and biotech industry.
Ortuvo has completed 1 funding round, raising a total of $256.00K. The latest funding stage is Grant.
Top alternatives and competitors to Ortuvo include KaloCyte, Inc., AdBioInk Biosystem Technology, Cyfuse Biomedical K.K., Kiwi Biosciences, Axolotl Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ortuvo and KaloCyte, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ortuvo, https://bouncewatch.com/company/ortuvo, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes